SCHEMBL2463151

SCHEMBL2463151

Cc1cc(C)cc(P(c2cc(C)cc(C)c2)c2cccc(C)n2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.41
CCR8 P51685 1/20 0.41
NOS3 P29474 1/20 0.39
NOS2 P35228 1/20 0.39
ACHE P22303 1/20 0.37
RAB9A P51151 4/20 0.33
GBA1 P04062 1/20 0.33
MAPT P10636 1/20 0.33
GRM5 P41594 4/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
CYP1A2 P05177 3/20 0.32
ALDH1A1 P00352 3/20 0.32
NPC1 O15118 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HDAC6 Q9UBN7 2/20 0.32
KDM4E B2RXH2 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C9 P11712 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1218581 0.86 ACHE (0.41) CCR1CCR8NOS3NOS2ACHE
SCHEMBL1219902 0.84 CCR1 (0.41) CCR1CCR8NOS3NOS2ACHE
SCHEMBL955795 0.83 CCR1 (0.52) CCR1CCR8NOS3NOS2RAB9A
SCHEMBL231108 0.82 KDM4E (0.45) CCR1CCR8NOS3NOS2RAB9A
SCHEMBL2230533 0.81 NOS2 (0.45) NOS3NOS2ACHERAB9AALDH1A1
SCHEMBL28509210 0.80 KDM4E (0.44) CCR1CCR8NOS3NOS2RAB9A
SCHEMBL11903943 0.79 LMNA (0.34) CCR1CCR8NOS3NOS2RAB9A
SCHEMBL11903995 0.78 NOS2 (0.38) NOS3NOS2ACHE
SCHEMBL1217571 0.78 KDM4E (0.50) CCR1CCR8NOS3NOS2RAB9A
SCHEMBL1219260 0.77 TGFBR1 (0.41) CCR1CCR8NOS3NOS2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120214999-A1 METAL COMPLEX, PYRIDYLPHOSPHINE COMPOUND, AND METHOD FOR PRODUCING ALKYL METHACRYLATE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-23 US claimed
EP-2487179-A1 METAL COMPLEX, PYRIDYLPHOSPHINE COMPOUND, AND METHOD FOR PRODUCING ALKYL METHACRYLATE Sumitomo Chemical Co., Ltd (JP) 2012-08-15 EP claimed
EP-2828232-B1 PROCESS FOR PRODUCING ALKYL METHACRYLATE SUMITOMO CHEMICAL CO (JP) 2016-04-20 EP disclosed
EP-2828232-A1 PROCESS FOR PRODUCING ALKYL METHACRYLATE Sumitomo Chemical Company Limited (JP) 2015-01-28 EP disclosed
WO-2013141004-A1 PROCESS FOR PRODUCING ALKYL METHACRYLATE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-09-26 WO disclosed
US-20120214999-A1 METAL COMPLEX, PYRIDYLPHOSPHINE COMPOUND, AND METHOD FOR PRODUCING ALKYL METHACRYLATE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-23 US disclosed
EP-2487179-A1 METAL COMPLEX, PYRIDYLPHOSPHINE COMPOUND, AND METHOD FOR PRODUCING ALKYL METHACRYLATE Sumitomo Chemical Co., Ltd (JP) 2012-08-15 EP disclosed
WO-2011111806-A1 METHOD FOR PRODUCING α, β-UNSATURATED CARBOXYLATE, AND CATALYST FOR PRODUCING THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214999-A1 METAL COMPLEX, PYRIDYLPHOSPHINE COMPOUND, AND METHOD FOR PRODUCING ALKYL METHACRYLATE AP1M1, MPHOSPH6, MACO1 CCR1 1777/4885CCR8 2796/4885NOS3 3631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.